Cybin Awarded Grant For NYC Hospital Psychedelic Clinic

Psychedelic therapy company Cybin Inc. (NEO:CYBN) (NYSE: CYBN) has been awarded a grant for the first psychedelic treatment clinic at Lenox Hill Hospital, part of Northwell Health, to serve marginalized and underserved communities on the Upper East Side of Manhattan, New York.  The program has hopes to become one of the first hospital-based clinical sites to offer psychedelic medicine in the United States.

“Lenox Hill Hospital is excited by the potential of these modalities for the treatment of previously intractable conditions such as severe depression, chronic PTSD, and OCD,” said David Roane, MD, Chairman of Psychiatry at Lenox Hill Hospital.  “With this grant from Cybin, Lenox Hill Hospital aims to become one of the first hospital-based clinical sites offering psychedelic medicine in the country and is dedicated to addressing health inequities by prioritizing care for marginalized and underserved populations. In particular, people of color are greatly underrepresented in psychedelic research studies and our team is committed to inclusive recruitment of patients.”

The company said in a statement that clinicians will also receive training in EMBARK, a transdiagnostic psychedelic psychotherapy model that can be adapted to address a range of clinical indications and populations.  EMBARK is Cybin’s psychotherapy model created by Dr. Alex Belser, Cybin’s Chief Clinical Officer and Bill Brennan, Ph.D. (cand.).

“It’s time for psychedelic medicine to climb down from the ivory tower and into the community.  We are honored to support this program at Lenox Hill Hospital to start a low-cost/no-cost psychedelic-clinic for marginalized and underserved communities in New York,” said Dr. Alex Belser, Chief Clinical Officer of Cybin.

Lenox Hill Hospital is a 450-bed, acute care facility on Manhattan’s Upper East Side and the flagship Manhattan hospital of privately owned Northwell Health – the largest healthcare system in New York State.  Highlights of the program include:

  • Founded by Kimia Pourrezaei, DO, and Gregory Mendoza, LCSW-R, of the Lenox Hill Hospital Outpatient Center for Mental Health, the clinical program is dedicated to addressing health inequities by prioritizing care for marginalized and underserved populations;
  • The program will increase accessibility by offering treatment with no out of pocket cost for individuals who would otherwise be unable to afford this service;
  • The clinic plans to also provide psychedelic treatments to frontline healthcare workers affected by COVID-19;
  • Clinicians will receive training in MDMA-, ketamine-, and tryptamine-assisted psychotherapy.

Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 1 hour

The Weekly Stash Video September 30, 2022

@GreenMarketRpt – 2 hours

Florida Drops Criminal Charges Against Former Ascend Wellness Chief

@GreenMarketRpt – 2 hours

Grown Rogue Remains Disciplined As Growth Slows

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.